Quick Search 
Drugs of the Future
Register or sign in

  
 
  
Volume 43, Issue 2, February 2018, Pages 87-155
 
MONOGRAPHS
 
  
 Idasanutlin.
MDM2 (Hdm2) inhibitor, Treatment of acute myeloid leukemia, Hematological cancer therapy.
Gras, J.
Drugs Fut 2018, 43(2): 87
Summary | Full Text: PDF 
 
  
  
 Ravidasvir hydrochloride.
Second-generation NS5A inhibitor, Treatment of hepatitis C virus infection.
Waked, I., Omar, H., Elbaz, T., Esmat, G.
Drugs Fut 2018, 43(2): 97
Summary | Full Text: PDF 
 
  
  
 Umbralisib tosylate.
Phosphatidylinositol 3-kinase δ (PI3Kδ) inhibitor, Hematological cancer therapy.
Moro, L.
Drugs Fut 2018, 43(2): 109
Summary | Full Text: PDF 
 
  
 
DRUGLINE
 
  
 Pipeline on the move.
Torramade, E., Gonzalez Brao, M.M., Mila, M.
Drugs Fut 2018, 43(2): 121
Full Text: PDF 
 
  
 
MEETING REPORTS
 
  
 17th Annual PepTalk: The Protein Science Week 2018. San Diego, California, USA – January 8-12, 2018.
Schmidt, S.R., Bofill, X.
Drugs Fut 2018, 43(2): 131
Summary | Full Text: PDF 
 
  
  
 Human Amyloid Imaging (HAI) Conference. Miami Beach, Florida, USA – January 17-19, 2018.
Cole, P., Bofill, X.
Drugs Fut 2018, 43(2): 139
Summary | Full Text: PDF 
 
  
  
 2018 Gastrointestinal Cancers Symposium. San Francisco, California, USA – January 18-20, 2018.
Cole, P., Bofill, X.
Drugs Fut 2018, 43(2): 143
Summary | Full Text: PDF 
 
  
  
 ASCO-SITC Clinical Immuno-Oncology Symposium. San Francisco, California, USA – January 25-27, 2018.
Cole, P., Bofill, X.
Drugs Fut 2018, 43(2): 153
Summary | Full Text: PDF 
 
  
 
  



© 2022 Clarivate. All rights reserved.
Copyright NoticeTerms of UsePrivacy StatementCookie PolicyManage cookie preferences